RxDoctor Payments Data

Denise Hiser-Ruddick

Family · Syracuse, NYNPI 1750512851

Payments from drug & device makers

$5,460in general payments, 2019–2025

Across 223 payments — averaging $24.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • GSK$810
  • Takeda Pharmaceuticals U.S.A., Inc.$594
  • Sanofi$576
  • Pfizer$268
  • CSL Behring$260
  • plus $2K from 21 others

What the payments were for

  • Consulting fees$321%
  • Food & beverage$5,29597%
  • Education$1332%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,460 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.

See all family providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter83$92,896
Breo ElliptaFluticasone/Vilanterol38$26,421
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$22,513
Mometasone Furoate44$5,356
Epinephrine16$3,829
Azelastine Hcl88$3,677
Albuterol Sulfate HfaAlbuterol Sulfate76$3,197
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$3,181
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$2,283
Desloratadine19$1,517
Levocetirizine Dihydrochloride61$1,487
Fluticasone Propionate60$1,112
Ipratropium Bromide28$1,062
Montelukast Sodium28$253
Prednisone12$63

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$810$119,318121 claims
AstraZenecaBreztri Aerosphere$1,441$22,51316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.

Other family in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →